Ł Fiszer‐Maliszewska

ŁF

Publications

367

Citations

H-Index

1990

Active since

Affiliations

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy(Current)

Pomeranian Medical University

Polish Academy of Sciences

International Hereditary Cancer Center

Lublin Oncology Center

Ł Fiszer‐Maliszewska is an author at Ludwik Hirszfeld Institute of Immunology and Experimental Therapy specializing in cancer research, clinical trials, and tumor biology.

Top concepts

HealthMedicineOncologyImmunologyPharmacologyImmunotherapyTumor BiologyCancer TherapyCancer ResearchClinical Trials

Publications per year

1990–2018

Publications

A high proportion of founder BRCA1 mutations in Polish breast cancer families

Bohdan Górski, Anna Jakubowska, Tomasz Huzarski et al. · International Journal of Cancer · 2004 · 192 citations

Evidence for Selective Expression of the p53 Codon 72 Polymorphs: Implications in Cancer Development

Monowarul Mobin Siddique, Balram Chowbay, Ł Fiszer‐Maliszewska et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 75 citations

Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study)

Grzegorz Kurzawski, Janina Suchy, Marcin Lener et al. · Clinical Genetics · 2005 · 42 citations

Introduction of the activated N-ras oncogene into human fibroblasts by retroviral vector induces morphological transformation and tumorigenicity

Anne R. Kinsella, Ł Fiszer‐Maliszewska, Erika L.D. Mitchell et al. · Carcinogenesis · 1990 · 19 citations

Local low-dose IL-2 therapy.

Den Otter W, Lianne T. M. Balemans, Battermann Jj et al. · PubMed · 1999 · 18 citations

Il-2 Therapy, Immunology, Pharmacotherapy +18

Rows per page

1–5 of 7